VM

Vivek Malaviya

Active Director Director DIN 06942962
DIN 06942962 First appointment Aug 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Vivek Malaviya

Data last updated:

Vivek Malaviya is a Director at Dem Pharmaceuticals Private Limited (since 2014). The company operates in Chemicals.

DIN 06942962
Primary Designation Director
Industry Chemicals
First Appointment 26 Aug 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dem Pharmaceuticals Private Limited U74140DL2014PTC270926
Director26 Aug 20142014Active

Board colleagues of Vivek Malaviya

NameDINCompanyDesignation
Neha Malviya07586834Dem Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Dem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vivek Malaviya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Malaviya

Vivek Malaviya currently holds 1 directorship: Dem Pharmaceuticals Private Limited (Director, since 26 Aug 2014).

Vivek Malaviya was first appointed on 26 Aug 2014 as Director at Dem Pharmaceuticals Private Limited.

The current boards of Vivek Malaviya's companies include Neha Malviya (Dem Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available